Shapira, I., Andrade, D., Allen, S.L. and Salmon, J.E. (2012) Brief Report: Induction of Sustained Remission in Recurrent Catastrophic Antiphospholipid Syndrome via Inhibition of Terminal Complement with Eculizumab. Arthritis & Rheumatism, 64, 2719-2723.
https://doi.org/10.1002/art.34440

has been cited by the following article:

• TITLE: Bilateral Carotid Aneurysms Secondary to Catastrophic Antiphospholipid Syndrome in a Patient with Differential Diagnosis of Polyarteritis Nodosa

  AUTHORS: Alexandre Sacchetti Bezerra, Fernanda Gonçalves Moya, Idalecio Souto Fonseca Filho, Alexandre Cesar Fioretti

  KEYWORDS: Aneurism, Anticardiolipin Antibodies, Antiphospholipid Syndrome, Carotid Artery, Thrombosis

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.12 No.1, January 25, 2022

  ABSTRACT: Background: Extracranial Carotid Artery Aneurysm is considered a therapeutic and diagnostic challenge. In an unprecedented way in the literature, wedescribe an aneurysm originating from the Catastrophic Antiphospholipid Syndrome. Case Presentation: A 25-year-old male patient came to the Emergency Room of the ABC University Hospital in Sao Bernardo do Campo referring to bilateral neck pain for 1 month, associated with carotid aneurysms. Due to the severity and urgency of the clinical condition, immediate surgical therapy was performed without a definitive etiological diagnosis. The initial morphological analysis of the carotid artery suggested a diagnosis of Polyarteritis Nodosa. After anamnesis, physical examination, the use of a specific primary vasculitisalgorithm, and a review of the pathological anatomy was requested, which showed bilateral carotid aneurysms secondary to catastrophic antiphospholipid syndrome. Conclusion: It remains evident that Extracranial Carotid Artery Aneurysm-related morbidity and mortality caused by Catastrophic Antiphospholipid Syndrome areinfluenced by a quick and correct diagnosis.